Banu Aygün

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

Russell E. Ware, Barry R. Davis, William H. Schultz et al. · The Lancet · 2015 · 514 citations · Full text

Medicine, Hematology, Pediatrics +12

Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

Léon Tshilolo, George Tomlinson, Thomas N. Williams et al. · New England Journal of Medicine · 2018 · 376 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemia

Russell E. Ware, Jenny M. Despotovic, Nicole A. Mortier et al. · Blood · 2011 · 168 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Genetic predictors for stroke in children with sickle cell anemia

Jonathan M. Flanagan, Denise M. Frohlich, Thad A. Howard et al. · Blood · 2011 · 147 citations · Full text

Medicine, Genetics, Hematology +14

Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin

Duyen Ngo, Banu Aygün, Idowu Akinsheye et al. · British Journal of Haematology · 2011 · 135 citations · Full text

Life Sciences, Genetics, Hematology +11